Mirina Corporation Obtains Series A Round

  • Feed Type
  • Date
    4/26/2010
  • Company Name
    Mirina Corporation
  • Mailing Address
    161 Eastlake Avenue E. Seattle, WA 98102
  • Company Description
    The company develops microRNA therapeutics.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Series A
  • Proceeds Purposes
    We’re very pleased our team at Mirina has successfully executed on its milestones over the past 20 months and has generated an impressive amount of promising data. This additional investment will allow the company to aggressively pursue moving candidates toward clinical development.
  • M&A Terms
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Alexandria Real Estate Equities, Inc.
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    WRF Capital

Trending on Xconomy